Skip to main content
. 2023 Apr 4;24(7):6731. doi: 10.3390/ijms24076731

Table 1.

Demographic and clinical characteristics of enrolled patients.

Sex Patient No. Percentage
Female/Male 27/28 49/51
Type of tumor
Lung cancer 33 60
Melanoma 10 18
Breast cancer 6 10
Kidney cancer 2 4
Head and neck cancer 2 4
Gastrointestinal cancer 2 4
Type of oncological treatment
ICIs + chemotherapy 6 11
ICIs 32 58
Chemotherapy 17 31
Type of ICI
Pembrolizumab 20 36
Nivolumab 12 22
Atezolizumab 4 7
Durvalumab 2 4

Legend: ICI: immune-checkpoint inhibitor.